What's more, numerous properly recognized adverse prognostic markers, including U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, misplaced their damaging influence in people addressed with VO. The only real variable that remained predictive of the shorter development-no cost survival in this cohort of patients was TP53 aberrations.112 Lastly, the